[1] 赵晓利,李力.宫颈癌治疗模式进展.国外医学肿瘤学分册,2004,31(5):380-383.
[2] Mukherjee G, Freeman A, Moore R, et al. Biologic factor and response to radiotherapy in carcinoma of the cervix. Int J Gynecol Cancer,200t, 11(3):187-193.
[3] Wootipoom V, Lekhyananda N, Phungrassami T, et al. Prognostic significance of Bar, bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy. Gynecol Oncol, 2004, 94(3):636-642.
[4] Arafat WO, Gomez-Navarro J, Xiang J, et al. An adenovirus encoding proapoptotic bax induces apoptosis and enhances the radiation effect in human ovarian cancer. Mol Ther, 2001, 1(6):545-554.
[5] Kokunai T, Urui S, Tomita H, et al. Overcoming of radioresistance in human gliomas by p21WAF1/CIP1 antisense oligonucleotide. J Neuro Oncol, 2001, 51(2):111-119.
[6] Suzuki Y, Nakano T, Kato S, et al. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone:p53 status has a strong impact on prognosis. Int J Radiat Oncol Biol Phys, 2004, 60(1):231-236.
[7] Ishikawa H, Mitsuhashi N, Sakurai H, et al. The effects of p53 status and human papillomavirus infection on the elinical outcome of patients with stage ⅢB cervical carcinoma treated with radiation therapy alone. Cancer, 2001, 91(1):80-89.
[8] Abdulkarim B, Sabri S, Deutsch E, et al. Antiviral agent cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene, 2002, 21(15):2334-2346.
[9] 苏景伟,于世英,张孟贤,等.p21/WAF-1/CIP-1与宫颈癌放射敏感性的关系.中华放射肿瘤学杂志,2005,14(1):17-18.
[10] 王建东,高菊珍,杨伟志.增殖细胞核抗原和毛细血管间距与宫颈癌放射敏感性的关系.中华放射肿瘤学杂志,2001,10(2):122-125.
[11] Cho NH, Kim YB, Park TK, et al. P63 and EGFR as prognosis p redictor in stage ⅡB radiation treated cervical squamous cell cercinoma. Gynecol Oncol, 2003, 91(2):346-353.
[12] Niibe Y, Nakano T, Ohno T, et al. Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy. Int J Gynecol Cancer, 2003, 13(6):849-855.
[13] Bachtiary B, Schindl M, Potter R, et al. Overexpression of hypoxiainducible factor-1 alpha indicatas diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res, 2003, 9(6):2234-2240.
[14] Ishikawa H, Sakurai H, HasegawaM, et al. Expression of hypoxicinducible factor-1 alpha predicts metastasis-free survival after radiation therapy alone in stage Ⅲ B cervical squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 2004, 60(2):513-521.
[15] Vordermark D, Brown JM. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?. Strahlenther Onkol,2003, 179(12):801-811.
[16] Airley RE, Loncaster J, Raleigh JA, et al. GLUT-1 and CA IX as intrinsicmarkers of hypoxia in carcinoma of the cervix:relationship to pimonidazole binding. Int J Cancer, 2003, 104(1):85-91.
[17] Kitahara O, Katagiri T, Tsunoda T, et al. Classification of sensitivity or resistance of cervical cancer to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis.Neoplasia, 2002, 4(4):295-303.
[18] Harima Y, Togashi A, Horikoshi K, et al. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys, 2004, 60(1):237-248.
[19] Achary MP, Jaggemauth W, Gross E, et al. Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression. Cytogenet Cell Genet, 2000, 91(1-4):39-43.
[20] Tewari D, Monk BJ, Al-Ghazi MS, et al. Gene expression profiling of in vitro radiation resistance in cervical carcinoma:a feasibility study. Gynecol Oncol, 2005, 99(1):84-91.